Table 1.
Demographic and clinical characteristics of HEAL participants with baseline and QOL follow-up data (n = 803)
| Characteristic | n | % |
|---|---|---|
| Baseline Characteristics | ||
| Location | ||
| New Mexico | 439 | 54.7 |
| Western Washington | 166 | 20.7 |
| Los Angeles | 198 | 24.7 |
| Age (yr) | ||
| 29-49 | 238 | 29.6 |
| 50-59 | 301 | 37.5 |
| 60-69 | 178 | 22.2 |
| 70+ | 86 | 10.7 |
| (mean ± sd) | (55.5 ± 10.4) | |
| Education | ||
| HS or less | 205 | 25.6 |
| Some college | 293 | 36.5 |
| College grad | 155 | 19.3 |
| Grad school | 149 | 18.6 |
| (missing) | (1) | |
| Race/Ethnicity | ||
| Non-Hispanic White | 485 | 60.4 |
| Black | 199 | 24.8 |
| Hispanic | 95 | 11.8 |
| Other | 24 | 3.0 |
| Stage at diagnosis | ||
| in situ | 178 | 22.2 |
| Local | 453 | 56.4 |
| Regional | 172 | 21.4 |
| Treatment type | ||
| Surgery only | 259 | 32.3 |
| Surgery/Radiation | 296 | 36.9 |
| Surgery/Chemotherapy | 74 | 9.2 |
| Surgery/Radiation/Chemotherapy | 174 | 21.7 |
| 24-Month Assessment Follow-up Characteristics | ||
| Marital status | ||
| Currently married or in a partnered relationship | 450 | 58.2 |
| Widowed/divorced/separated | 272 | 35.2 |
| Never married | 51 | 6.6 |
| (missing)* | (30) | |
| Current employment | ||
| Currently working | 449 | 58.0 |
| Unemployed (on leave, looking for work) | 26 | 3.4 |
| Not working outside the home/retired/disabled | 299 | 38.6 |
| (missing)* | (29) | |
| Income ($) | ||
| <= 10K | 54 | 7.5 |
| >10K – 20K | 86 | 11.9 |
| >20K – 30K | 93 | 12.9 |
| >30K – 50K | 168 | 23.2 |
| >50K – 70K | 210 | 29.0 |
| >70K | 113 | 15.6 |
| (missing)* | (79) | |
| Menopausal status | ||
| Pre | 142 | 18.3 |
| Post | 589 | 75.9 |
| Unclassifiable | 45 | 5.8 |
| (missing)* | (27) | |
| Months from diagnosis to QOL survey | ||
| 23 - 35 | 192 | 23.9 |
| 36 - 41 | 274 | 34.1 |
| 42 – 47 | 209 | 26.0 |
| 48 – 63 | 128 | 15.9 |
| (mean ± sd) | (40.5 + 6.5) | |
| Tamoxifen | ||
| Use between baseline & 24 mo | 350 | 45.1 |
| Use at or before baseline only | 69 | 8.9 |
| No use during study period | 357 | 46.0 |
| (missing)* | (27) | |
| Antidepressants | ||
| Currently taking at 24 mo | 119 | 15.3 |
| Not currently taking at 24 mo | 657 | 84.7 |
| (missing)* | (27) |
*
Includes women with baseline and QOL data who did not complete a 24-month assessment (n = 27).